Loading
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Jun 2026 for DAXOR CORP. Read the official filing
Filing timeline
BuySaleRobert J. Michel
Insider track record
Disclosed buys
10
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-0.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Robert J. Michel: trading record in brief
Robert J. Michel is a declared insider at 2 companies (finance chief); the most frequent names are BIO KEY International Inc and Daxor Corp. We count 38 filings; the first trade dates from 13 May 2021 and the latest from 23 June 2026.
No open-market sale appears; the market trades are 10 purchases worth €42k. The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 28 share grants. So far in 2026, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €5,152. On 6 out of 8 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 25 June 2026, the filings show a share grant in Daxor Corp. The last insider purchase was made public on 31 March 2026, 201 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert J. Michel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
12,000 sharesDaxor Common StockSEC:0001493152-26-030197:0
1,000 shares@ US$9.9020.5% of flowDaxor Common StockSEC:0001493152-26-014397:0
Canonical exit: 29 Jun 2026 (T+90)
3,000 shares0Daxor Common StockSEC:0001493152-25-027230:0
Canonical exit: 9 Mar 2026 (T+90)
5,000 shares0Common StockSEC:0001437749-25-018529:0
1,266 shares@ US$0.79100.0% of flowCommon StockSEC:0001437749-25-018529:1
3,897 shares0Common StockSEC:0001437749-25-016147:0
2,971 shares0Common StockSEC:0001437749-25-008779:0
1,000 shares@ US$8.0022.3% of flowDaxor Common StockSEC:0001493152-25-009800:0
Canonical exit: 8 Jun 2025 (T+90)
4,750 shares0Daxor Common StockSEC:0001493152-24-049527:0
Canonical exit: 25 Jun 2023 (T+90)
2,587 shares0Common StockSEC:0001437749-24-034243:0
3,500 shares0Common StockSEC:0001437749-24-024531:0
1,429 shares0Common StockSEC:0001437749-24-010087:0
750 shares@ US$8.7018.2% of flowDaxor Common StockSEC:0001493152-24-011454:0
Canonical exit: 25 Jun 2024 (T+90)
120 shares@ US$7.752.6% of flowDaxor Common StockSEC:0001493152-23-043860:0
Canonical exit: 5 Mar 2024 (T+90)
180 shares@ US$7.753.9% of flowDaxor Common StockSEC:0001493152-23-043472:0
Canonical exit: 29 Feb 2024 (T+90)
500 shares@ US$7.9411.0% of flowDaxor Common StockSEC:0001493152-23-042692:0
Canonical exit: 22 Feb 2024 (T+90)
2,000 shares0Daxor Common StockSEC:0001493152-23-039200:0
500 shares@ US$9.0212.9% of flowDaxor Common StockSEC:0001493152-23-037321:0
Canonical exit: 11 Jan 2024 (T+90)
1,819 shares0Common StockSEC:0001437749-23-024908:0
4,412 shares0Common StockSEC:0001437749-23-023645:0
4,348 shares0Common StockSEC:0001437749-23-014593:0
1,429 shares0Common StockSEC:0001437749-23-013048:0
3,847 shares0Common StockSEC:0001437749-23-007290:0
1,000 shares@ US$10.0029.2% of flowDaxor Common StockSEC:0001493152-22-032891:0
Canonical exit: 16 Feb 2023 (T+90)
2,098 shares0Common StockSEC:0001437749-22-027220:0
25 of 38 declarations
